Thursday, August 27, 2020 6:29:26 AM
I would reverse that and say; 'why?'
Merck simply isn't in the game of acquiring autologous immunotherapy platforms that involve complex individualised manufacturing processes.
It doesn't fit their business model.
Which is basically; 'pile it high, sell it at an exorbitant price'.
And that is epitomised by the pembrolizumab example, which involves mass production of an off the shelf product. Low unit cost and 90% mark-up.
Pembro is expected to become the biggest grossing drug in the world, in about another years time.
Why would they wish to acquire the DCVax platform?
The only reason I could see, is so that they could run a couple of 'design to fail' Direct P2's, and then quietly terminate any further development. Though I guess they might consider that a value investment at the acquisition price that you suggested.
That's the only reason that I can see, as to why they would even consider it.
And it's not what I would want to happen with my investment anyway, which goes beyond being purely financial.
And I don't think it's what LP really wants either, imo.
Though I guess the old maxim of 'everyone has their price' still holds true at least to some extent.
It really depends on whether you think that LP has a similar psychology and similar motivation to somebody like Arie Belldegrun.
Who did a fantastic job (purely in terms of personal aggrandisement) of fattening up Kite for market, and personally walking away with something like $700m, when Gilead came along.
https://endpts.com/the-913m-bonanza-arie-belldegrun-and-his-top-team-at-kite-shows-you-how-to-make-a-really-rich-deal/
How many patients worldwide have been treated with Yescarta?
Probably less than 10,000.
That deal will have chastened Gilead and the rest of BP. And made it less likely that there will be a queue lining up to acquire NWBO.
JMO!
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM